SK
Sanjay Kumar Singh
About Sanjay Kumar Singh
Data last updated:
Sanjay Kumar Singh is a Director at Redis Pharma Private Limited (since 2023) and Director at Redmax Pharma Private Limited (since 2025). The companies operate in Business Services and Pharma. The largest current company by reported revenue is Redis Pharma Private Limited at ₹6.3 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Redis Pharma Private Limited U74999BR2020PTC048609 | Director | 04 Aug 2023 | 2020 | ₹6.3 Lakh (FY 2024) | Active |
| Redmax Pharma Private Limited U46497BR2025PTC075648 | Director | 01 May 2025 | 2025 | Active |
Board colleagues of Sanjay Kumar Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Srijan Parashar | 08121387 | Redis Pharma Private Limited , Redmax Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sanjay Kumar Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanjay Kumar Singh
Sanjay Kumar Singh currently holds 2 directorships: Redis Pharma Private Limited (Director, since 04 Aug 2023, revenue ₹6.3 Lakh (FY 2024)); Redmax Pharma Private Limited (Director, since 01 May 2025).
Sanjay Kumar Singh was first appointed on 04 Aug 2023 as Director at Redis Pharma Private Limited. The most recent appointment on record is 01 May 2025 at Redmax Pharma Private Limited.
The current boards of Sanjay Kumar Singh's companies include Srijan Parashar (Redis Pharma Private Limited).